|
|
|
|
|
|
by rorykoehler
2786 days ago
|
|
|
I can totally understand your choices though I think we can both agree that the current drug choices are very primitive due to their systemic efficacy. There are some interesting mouse studies that are investigating methods of targeted secretion of biologic drugs using CRISPR (modified viruses?) at the site of inflammation [1]. I'm hoping these progress to human trials soon. [1] https://www.technologynetworks.com/genomics/news/a-crispr-ba... |
|
|